Assessment of prognosis in patients with community-acquired pneumonia who require mechanical ventilation

Chest

Volumn 117, Issue 2, 2000, Pages 503-512

  Pascual, Fred E ^a,c   Matthay, Michael A ^b   Bacchetti, Peter ^b   Wachter, Robert M ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hypoxemia index; Intensive care; Mechanical ventilation; Outcome; Pneumonia; Prognosis

Indexed keywords

ACICLOVIR; AMOXICILLIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; AZTREONAM; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPSONE; DOXYCYCLINE; ERYTHROMYCIN; ETHAMBUTOL; FLUCONAZOLE; GENTAMICIN; IMIPENEM; ISONIAZID; ITRACONAZOLE; METRONIDAZOLE; NAFCILLIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TIMENTIN; TOBRAMYCIN; VANCOMYCIN;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; HYPOXEMIA; INTENSIVE CARE; LUNG ALVEOLUS OXYGEN TENSION; LUNG INJURY; MAJOR CLINICAL STUDY; MODEL; MORTALITY; MYCOSIS; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; RESPIRATORY FAILURE; SURVIVAL; VIRUS INFECTION;

EID: 0033994215     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.117.2.503     Document Type: Article

References (30)

1. 1 Leeper K. Severe community-acquired pneumonia. Semin Respir Infect 1996; 11:96-108
2. 2 Torres A, Serra-Batlles J, Ferrer A, et al. Severe community-acquired pneumonia: epidemiology and prognostic factors. Am Rev Respir Dis 1991; 144:312-318
3. 3 Moine P, Vercken J, Chevret S, et al. Severe community-acquired pneumonia: etiology, epidemiology, and prognostic factors. Chest 1994; 105:1487-1495
4. 4 Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis 1989; 11:586-599
5. 5 Sorensen J, Cederholm I, Carlsson C. Pneumonia: a deadly disease despite intensive care treatment. Scand J Infect Dis 1986; 18:329-335
6. 6 Almirall J, Mesalles E, Klamgurg J, et al. Prognostic factors of pneumonia requiring admission to the intensive care unit. Chest 1995; 107:511-516
7. 7 Leroy O, Santre C, Beuscart C, et al. A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med 1995; 21:24-31
8. 8 Leroy O, Georges H, Beuscart C, et al. Severe community-acquired pneumonia in ICUs: prospective validation of a prognostic score. Intensive Care Med 1996; 22:1307-1314
9. 9 Enger C, Graham N, Peng Y, et al. Survival from early, intermediate, and late stages of HIV infection. JAMA 1996; 275:1329-1334
10. 10 Salerno F, Borroni G, Moser P, et al. Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients. Am J Gastroenterol 1993; 88:514-519
11. 11 Strom K. Survival of patients with chronic obstructive pulmonary disease receiving long-term domiciliary oxygen therapy. Am Rev Respir Dis 1993; 147:585-591
12. 12 Smith W. Epidemiology of congestive heart failure. Am J Cardiol 1985; 55:3A-8A
13. 13 Mailloux L, Bellucci A, Napolitano B, et al. Survival estimates for 683 patients starting dialysis from 1970 through 1989: identification of risk factors for survival. Clin Nephrol 1994; 42:127-135
14. 14 Alexanian R, Dimopoulos M. The treatment of multiple myeloma. N Engl J Med 1994; 330:484-489
15. 15 Greenberg P, Cox C, Lebeaux M, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89:2079-2088
16. 16 Buchner T, Heinecke A. The role of prognostic factors in acute myelogenous leukemia. Leukemia 1996; 10(Suppl 1): S28-S29
17. 17 Murray JF, Matthay M, Luce J, et al. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138:720-723
18. 18 Le Gall JR, Loirat P, Alperovitch A, et al. A simplified acute physiology score for ICU patients. Crit Care Med 1984; 12:975-977
19. 19 Knaus W, Draper E, Wagner D, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-829
20. 20 Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-824
21. 21 Knaus W, Draper E, Wagner D, et al. Prognosis in acute organ-system failure. Ann Surg 1985; 202:685-693
22. 22 Hosmer D, Lemeshow S. Applied logistic regression. New York, NY: Wiley, 1989; 140-145
23. 23 Efron B, Gong G. A leisurely look at the bootstrap, the jacknife, and cross-validation. Am Statistician 1983; 37:36-48
24. 24 Beck J, Shultz E. The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med 1986; 110:13-20
25. 25 Pearlman R. Variability in physician estimates of survival for acute respiratory failure in chronic obstructive pulmonary disease. Chest 1987; 91:515-521
26. 26 Perkins H, Jonsen A, Epstein W. Providers as predictors: using outcome predictions in intensive care. Crit Care Med 1986; 14:105-110
27. 27 Poses R, Bekes C, Copare F, et al. The answer to "what are my chances, doctor?" depends on whom is asked: prognostic disagreement and inaccuracy for critically ill patients. Crit Care Med 1989; 17:827-833
28. 28 Brown M, Crede W. Predictive ability of APACHE II scoring applied to HIV-positive patients. Crit Care Med 1995; 23: 848-853
29. 29 Niskanen M, Kari A, Nikki P, et al. APACHE II and Glasgow coma scores as predictors of outcome from intensive care after cardiac arrest. Crit Care Med 1991; 19:1465-1473
30. 30 Schaefer J, Jochimsen F, Keller F, et al. Outcome prediction of acute renal failure in medical intensive care. Intensive Care Med 1991; 17:19-24